help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ewart-Toland, A.
Right arrow Articles by Chehab, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ewart-Toland, A.
Right arrow Articles by Chehab, F. F.
Endocrinology Vol. 140, No. 2 732-738
Copyright © 1999 by The Endocrine Society


ARTICLES

Effect of the Genetic Background on the Reproduction of Leptin-Deficient Obese Mice*

Amanda Ewart-Toland, Khalid Mounzih, Jun Qiu and Farid F. Chehab

Department of Laboratory Medicine, University of California, San Francisco, California 94143-0134

Address all correspondence and requests for reprints to: Farid F. Chehab, Ph.D., Department of Laboratory Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, California 94143-0134. E-mail: chehab{at}pangloss.ucsf.edu * This


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Obesity is often associated with an impairment of the hypothalamic-pituitary-gonadal axis. The leptin-deficient ob/ob mouse model is characterized by a morbid obesity with a sterility in males and females that is corrected by continuous leptin treatment. Since ob/ob mice are maintained on the C57BL/6J inbred genetic background, we sought to determine whether their infertility can be corrected without leptin treatment but via the effect of modifier genes brought into the obese-sterile phenotype by a different genetic background. Thus, we generated via an F2 intercross ob/ob mice on a mixed C57BL/6J-BALB/cJ genetic background and assayed them for fertility by mating with wild-type C57BL/6J mice. Whereas genetically heterogeneous F2 obese females remained sterile like male and female C57BL/6J ob/ob mice, 41% of F2 C57BL/6J-BALB/cJ obese males were capable of reproducing despite a morbidly obese state. Therefore, the sterility of the original C57BL/6J ob/ob mouse model was genetically corrected independently of its obese state via the effects of modifier genes. Unlike testosterone levels, triglyceride levels, and testes weight-to-body weight ratios, which were all higher in fertile vs. sterile mice, glucose levels were similar in both groups, indicating that the underlying hyperglycemia of ob/ob mice was not an impediment to the onset of fertility. A genome-wide scan in F2 ob/ob males resulted in the localization of four modifier loci on chromosomes 1, 3, 5, and 14 with respective quantitative traits consisting of number of pregnancies, testes weights normalized to body weights, body weight at 8 weeks of age, and circulating testosterone. We conclude that the inheritance of modifier genes at the identified loci acts to promote fertility of otherwise sterile leptin-deficient obese male mice.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN MODERN times, a sedentary lifestyle coupled with an abundance of food has significantly contributed to a rise in the number of overweight individuals in the Western population. In obese individuals, the reproductive axis is often impaired due to metabolic disturbances that affect central and peripheral networks, resulting in idiopathic infertility and hormonal dysregulation. In women, obesity causes extragonadal aromatization of androgens to estrogens (1), decreased sex hormone-binding globulin, and increased androgen production (2), raising the possibility that this milieu might alter the hypothalamic-pituitary-gonadal axis and predispose to the polycystic ovary syndrome in which approximately 40% of women are obese (3). In obese men, disruption of feedback loops at the hypothalamic-pituitary testicular and adrenal axes were found to be caused by a decrease in serum testosterone, sex hormone-binding globulin, and adrenal steroids that were inversely related to body mass index (4, 5). Since the etiology of obesity-related reproductive defects is broad and variable, treatment has centered around alleviation of the obese state, by either food restriction or drug treatment, rather than on the exact cause of the reproductive problem. To determine how impaired fertility can be improved in the presence of obesity, we investigated the sterility of leptin-deficient (ob/ob) obese mice. Leptin (6), a hormone secreted from adipose tissue and placenta (7, 8), is lacking in ob/ob mice, and its exogenous administration is sufficient to induce fertility in this mouse model (9, 10). Furthermore, leptin acts as an initiating and permissive factor for puberty, respectively, in normal mice (11, 12) and rats (13). Therefore, we reasoned that leptin’s stimulatory effect on the reproductive system could be substituted genetically by the effects of modifier genes or allelic variants brought into the obese-sterile phenotype from a different mouse strain than the one on which the ob mutation has been maintained. The uncovering of these modifier genes and their encoded products will thus unravel important signals that function with leptin on its action on the reproductive system.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice
Inbred mice on the BALB/cJJ background and ob/ob mice on the C57BL/6J background were purchased from The Jackson Laboratory (Bar Harbor, ME) and maintained at the UCSF Mouse Facility under a standard regimen of alternating 12-h light and dark periods. All procedures were approved by the UCSF Committee on Animal Research. All mice were fed ad libitum (FormuLab 5008 from Ralston-Purina Co., St. Louis, MO) with unrestricted access to water.

Generation of the intercross
The outcross consisted of inbred BALB/cJ lean females that were mated to leptin-treated C57BL/6J ob/ob males. Treatment of the ob/ob males with recombinant leptin was as previously described (5). The F1 heterozygous mice were intercrossed to generate an F2 progeny consisting of genetically heterogeneous males and females segregating the ob mutation in a Mendelian fashion. F2 mice were genotyped at the ob locus for the R105X mutation as previously described (4). None of the F2 ob/ob mice was treated with leptin.

Fertility assay
At 8 weeks of age, each F2 ob/ob male was housed with two 16- to 20-week-old reproductively competent lean C57BL/6J females that had had one to two pregnancies each since 8 weeks of age. Pregnant lean females were removed to individual cages and replaced by another lean female such that the obese males had two females continuously throughout the mating period. Pregnancies, deliveries, and number of pups were constantly monitored during the 15-week mating period. If obese males did not induce pregnancies in lean females within 4–6 weeks, two new females were substituted to the first pair to reduce chances of infertility in lean females. Similarly, ob/ob females were mated with two to three 16- to 20-week-old C57BL/6J stud males that had plugged lean females within 2–3 weeks before mating. Fertility was similarly assayed in males and females from the congenic C57BL/6J ob/ob strain. All obese males were killed at 23 weeks of age to collect blood and determine testes weights.

Metabolic assays
ob/ob mice were fasted for 15–17 h at 15–17 and 19–21 weeks of age, during which time they had access only to water. Blood was collected by tail bleeding and assayed immediately in duplicate for whole blood glucose with blood glucose test strips and the Encore Glucometer (Bayer Diagnostics, Elkhart, IN). Plasma glucose, albumin, amylase, cholesterol, and triglycerides were determined at 23 weeks of age on a Hitachi 747 Clinical Chemistry Analyzer (Hitachi Scientific Instruments, Inc., Mountain View, CA) from 14 fertile and 18 sterile obese males from whom blood was available. Plasma testosterone levels were determined in duplicate with a coated tube RIA kit (Diagnostic Systems Laboratories, Inc., Webster, TX).

Genome scan
Microsatellite markers that are polymorphic between the C57BL/6J and BALB/cJ mouse strains were selected from the mouse genome map. PCR primers were purchased from Research Genetics, Inc. (Huntsville, AL) or synthesized in-house on an ABI DNA synthesizer. All markers were chosen such that their amplification products were 5–50 bp different between the two strains with an average difference of 8–10 bp. DNA was extracted from either mouse tail biopsies or spleen recovered at 23 weeks of age by standard proteinase K/SDS method followed by phenol-chloroform extraction and DNA precipitation. Genotyping was performed by amplification of the PCR products for 35 cycles in standard conditions of 1.5 mM MgCl2, 100 µM deoxynucleoside triphosphates and thermocycling at 95 C, 55–58 C, and 72 C. The resulting PCR products were fractionated on 6% denaturing polyacrylamide gels and blotted onto Hybond N+ (Amersham Pharmacia Biotech, Arlington Heights, IL) nylon membranes by capillary transfer for at least 1 h. The Southern blots were then hybridized at 42 C from 1 h to overnight to a biotinylated (CA)10 oligonucleotide probe in 6xSSC and 0.5% SDS. The blots were then washed twice at room temperature in 2xSSC, 0.5% SDS for 5 min and finally in 0.5x SSC, 0.5% SDS at 42 C for 10 min. Detection of the hybridized probe was performed via the avidin-biotin conjugate system using a streptavidin horseradish peroxidase system. Briefly, the washed blot was incubated with 0.1 M Na citrate, pH 5, for 5 min at room temperature and then incubated for 15 min in the same buffer supplemented with 0.3 m g/ml streptavidin-peroxidase conjugate (Boehringer-Mannheim, Indianapolis, IN). Excess conjugate was washed off by incubation with two changes of 0.5xSSC, 0.5% SDS for 5 min at room temperature. The hybrids were visualized in a final incubation of the blot with 0.1 mg/ml of tetramethyl benzidine in 0.1 M Na citrate, pH 5.0. The reaction was stopped by transferring the blot to distilled water. This entire procedure of PCR and Southern blotting was necessary to increase confidence in genotyping and eliminate the interference of spurious PCR products associated with amplification of microsatellites. All double cross-overs were retyped for confirmation of the genotype.

Quantitative trait loci (QTL) analysis
Genotyping data were entered in the computer program MapManager/QTL vb21 that was downloaded from the Map Manager web site (http://mcbio.med.buffalo.edu/mmQT.html). Initially, the linkage map was constructed using 130 polymorphic microsatellite markers and then extended to additional 23 markers for fine mapping around the significant loci on chromosomes 1, 3, 5, and 14. Quantitative traits were correlated with genotypes at a specific locus by a regression analysis algorithm that measures associations using the likelihood ratio statistic (LRS) suggested by Haley and Knott (14). LRS values were converted to logarithm of the odds (LOD) scores according to Lander and Kruglyack (15) essentially by dividing them by 2(ln10)~=4.6. LOD scores were also calculated by importing the data from MapManager to the computer program QGene (a kind gift of Dr. Clare Nelson). Linkage was also evaluated with the MapManager permutation assay using 1000 permutated data sets (16) at each locus, thus setting up internal linkage thresholds. The LRS thresholds for number of pregnancies, testes weight (TW)/body weight (BW) ratio, TW, testosterone, and BW at 8 weeks were, respectively, 15.6, 14.4, 15.9, 16.7 and 21.7. All markers were analyzed as an F2 intercross except for X chromosome markers, which were analyzed as a backcross since there is only one chance of recombination for the X chromosome in a F2 male progeny when the outcross is between two inbred strains.

Statistics
Unless otherwise noted, data are expressed as means ± SEM. Statistical analysis was performed with the Statistica package obtained from Statsoft (Tulsa, OK). Student’s t test and linear regression analysis were performed to evaluate, respectively, differences between the fertile vs. sterile groups and to evaluate the correlation of various traits combined.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mating and BWs of F2 obese mice
Congenic C57 BL/6J ob/ob males were treated with recombinant leptin and mated with normal females from the BALB/cJ inbred genetic background. All mice in the F1 generation were obligate heterozygous at all loci including the ob locus. F1 mice were then bred with each other resulting in a F2 progeny randomly segregating C57BL/6J and BALB/cJ chromosomes. Unlike C57BL/6J ob/ob mice, which are maintained on a homogeneous genetic background and have essentially all the same genotype, each F2 ob/ob mouse is genetically unique as a result of random assortment of C57BL/6J and BALB/cJ chromosomes except for the Y chromosome that originates from the C57BL/6J ob/ob grandfathers. Overall, 272 F2 mice were generated, of which 34 were F2 obese males and 35 were F2 obese females. Two copies of the mutant ob allele segregated invariably with an obesity phenotype in the F2 population as determined by PCR typing (9) and BW determinations (data not shown). Obese males and females on the mixed genetic background gained weight rapidly after weaning and displayed by 12 weeks of age a morbid obesity comparable to that of the original C57BL/6J ob/ob strain (Fig. 1Go, A and B), thus demonstrating the severity and the highly penetrant nature of the obesity phenotype in males and females. Highly significant differences in BWs between mice on the C57BL/6J and F2 BALB/cJ-C57BL/6J backgrounds were found only in males at 23 weeks of age with respective BWs of 57.8 ± 7.1 g vs. 71.6 ± 4.9 g (means and SD; P = 10-7; t test) indicating that an adiposity-modifying effect is evident at a later age.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 1. Mean BWs (±SD) from 6–23 weeks of age of ob/ob male (A) and ob/ob female (B) mice maintained on either the C57BL/6J inbred (black bars) or the mixed F2 C57BL/6J-BALB/cJ (white bars) background. C, Number of pregnancies that ob/ob C57BL/6J (black) and ob/ob F2 (white) males induced in lean females. D, Mean BWs (±SD) of F2 fertile (white bars) and F2 nonfertile (black bars) ob/ob males from 6–23 weeks of age.

 
Sterility rescue of F2 obese mice
To determine whether the mixed genetic background influences the ability of F2 obese mice to reproduce in the absence of leptin, these mice were mated at 8 weeks of age to lean normal C57BL/6J mice for a period of 15 weeks. Monitoring of pregnancies throughout the mating period revealed that not a single ob/ob female from either the congenic control C57BL/6J (0 of 20 mice) or F2 C57BL-BALB/cJ (0 of 35 mice) strains was capable of sustaining a pregnancy. However, 14 of 34, or 41% of the F2 obese males induced one or more pregnancies that resulted in deliveries from normal females as opposed to 0 of 15 ob/ob males on the control C57BL/6J inbred background. The fertility of the 14 F2 obese males was variable as demonstrated by the number of pregnancies they induced in reproductively competent lean females throughout the mating period (Fig. 1CGo) and the ages at which they copulated with the lean females (Table 1Go). Thus, fertile F2 obese males induced their first and second pregnancies in lean females at 10.8 ± 0.6 and 14.2 ± 1.4 weeks of age, respectively. Furthermore, BW differences between fertile and nonfertile obese mice failed to reveal any statistical significance (Fig. 1DGo), indicating that excess BW was not an impediment to the onset of fertility that resulted from the segregation of modifier genes promoting fertility (mof). Furthermore, BWs of F2 obese mice at 6, 8, 10, 12, 16, and 23 weeks of age were normally distributed and revealed age-specific variations (Fig. 2Go, A–F), suggesting that modifier genes for adiposity (moa) are also expressed by the mixed genetic background and would thus be inherited with mof genes. Although there was no correlation between the number of pregnancies and BWs of the 34 F2 obese mice at any age, a correlation was found between the number of pregnancies of the 14 fertile obese mice and their respective BWs at 12 weeks of age (r = 0.55, P = 0.04). Taken together, these data suggest that moa genes segregate with mof genes contributing to the variation in the fertility phenotype observed in F2 fertile obese males.


View this table:
[in this window]
[in a new window]
 
Table 1. Ages (in weeks), number of pups, and genotypes of F2 ob/ob fertile males (1F–14F) that induced pregnancies (PR) in normal lean females

 


View larger version (35K):
[in this window]
[in a new window]
 
Figure 2. A–F, BW distribution of obese mice in the F2 population from 6–23 weeks of age. Distribution of TWs (G) and TWs normalized to BWs (H) in the F2 obese population.

 
Overall, a dissociation of the combined sterility and obesity phenotypes from the original C57BL/6J ob/ob strain had occurred in the F2 obese population as a result of a change in the genetic background of ob/ob mice. These observations demonstrate that modifier genes affecting fertility as well as adiposity segregate in the F2 progeny of this intercross.

Metabolic and physiological indexes in F2 obese males
To assess some of the metabolic parameters that could have contributed to the fertility of F2 obese males, glucose, cholesterol, triglycerides, amylase, albumin, and testosterone were measured in F2 obese males from plasma collected at 23 weeks of age. In addition, fasted blood glucose was determined at 15–17 weeks and 19–21 weeks of age (Table 2Go). Although albumin, amylase, glucose, and cholesterol levels were not statistically significant between fertile and sterile groups, testosterone and triglycerides levels were significantly more elevated in fertile obese males with respective P values of less than 0.05 and 0.01. Interestingly, triglyceride levels in fertile mice correlated with glucose levels at 23 weeks of age (r = 0.54; P < 0.002).


View this table:
[in this window]
[in a new window]
 
Table 2. Determination of metabolic and physiological indexes in F2 fertile and sterile obese males

 
Plasma testosterone levels in F2 obese mice were determined at 23 weeks of age and showed that F2 fertile obese mice had 2.6-fold higher circulating testosterone levels than nonfertile mice (Table 2Go; P < 0.05). We also examined whether testes weight of F2 obese mice could be an indicator of fertility as previous studies have shown that obese mice on the C57BL/6J background exhibit a hypogonadism characterized by lower testes weights than their lean counterparts (17, 18, 19). Paired testes weights of F2 obese mice followed a Gaussian distribution (Fig. 2GGo) but were not significantly different between fertile and sterile groups (Table 2Go). Furthermore, F2 obese mice showed a skewed ratio of TW vs. BW (TW/BW) as normal mice have testes weights approximating 0.38% of their BW (20) or 3.8 mg/g BW. In this study, TW/BW ratios were normally distributed (Fig. 2HGo) in the F2 population with the F2 fertile obese mice showing a higher ratio than F2 sterile obese mice (Table 2Go).

Chromosomal mapping of modifier loci
To identify the chromosomal localization of modifier loci affecting fertility and adiposity, we constructed a linkage map to assess the correlation of different fertility and obesity-related quantitative traits with the genotypes of F2 obese males at various loci throughout the genome. Thus, 153 microsatellite markers that are polymorphic between C57BL/6J and BALB/cJ strains were selected from the mouse genome map and spanned all except the Y chromosome. These markers were used to type the 34 F2 genetically heterogeneous obese males and the resulting genotypes entered in the Map Manager/QTL vb21 computer program. The ensuing F2 linkage map showed the markers to have an average spacing of 10.4 ± 0.5 centimorgans (cM). Since the number of pregnancies induced by fertile F2 obese males during the 15-week mating period was variable, we used the number of pregnancies as a fertility quantitative trait. Other quantitative traits included BW, absolute TW, TWs divided by BW (TW/BW), BW measured at 6, 8, 10, 12, 16, and 23 weeks of age, and each of the metabolic measurements shown in Table 2Go. Regression analysis of individual marker genotypes with the number of pregnancies quantitative trait identified a major locus on chromosome 1 at the D1MIT459 marker with a P value of 2.6 x 10-6 and an additive mode of inheritance. Interval mapping on chromosome 1 with this quantitative trait returned a likelihood ratio statistic (LRS) of 25.7 and a LOD score of 5.6 (Fig. 3AGo). These values vastly exceed the LOD score of 3.4 proposed by Lander and Kruglyack (15) as threshold for significant linkage. Furthermore, linkage to the D1MIT459 locus accounted for 53% of the phenotypic fertility variation. Two other loci that fell into the lower category of suggestive linkage were D3MIT316 (P = 0.0043; LRS = 10.9, LOD = 2.4) and D9MIT297 (P = 0.002, LRS = 12.4, LOD = 2.7).



View larger version (30K):
[in this window]
[in a new window]
 
Figure 3. Chromosomal localization of quantitative traits that influence the fertility of F2 ob/obmales. A, Linkage of the number of pregnancies/deliveries trait to chromosome 1. B, Linkage of two quantitative traits to the same region of chromosome 3. The continuous and dashed tracings represent, respectively, TW vs. BW and number of pregnancies/deliveries quantitative traits. C, Linkage of testosterone levels to chromosome 14. D, Linkage of BW of ob/ob mice at 8 weeks of age to chromosome 5.

 
Individual genotypes of fertile and sterile mice at the two loci on chromosomes 1 and 3 (Table 1Go) showed that fertile mice inherited more BALB/cJ alleles than nonfertile mice at both the D1MIT459 and D3MIT316 loci. Thus at both loci, F2 fertile obese mice had inherited 59% of BALB/cJ alleles vs. 33% in sterile obese (P = 0.005) mice, indicating that BALB/cJ modifier genes at these two loci may account, at least partly, for the differential fertility phenotype in the two groups. When fertility of obese mice was expressed as a discontinuous pseudodichotomous binary trait, rather than a continuous trait reflecting variation in the number of pregnancies, the number of BALB/cJ alleles inherited by the F2 obese population at the D1MIT459, D3MIT316 loci, or both correlated significantly (P < 0.05) with the binary fertility trait with regression coefficients of 0.40, 0.45, and 0.55, respectively.

On the other hand, with the TW/BW quantitative trait, D3MIT316, the marker previously identified with the number of pregnancies trait, emerged as the most significant association (P = 4.5 x 10-4; LRS = 15.6; LOD = 3.4). Therefore, the mapping of two different quantitative traits, TW/BW and number of pregnancies to the same region of chromosome 3 (Fig. 3BGo) strongly strengthens this association, thus identifying a second locus that influences the fertility of F2 obese males. Furthermore, since plasma testosterone levels were more elevated in fertile vs. nonfertile obese males, we sought to determine whether a modifier locus is associated with this quantitative trait. Thus, absolute testosterone levels in F2 obese males correlated significantly with genotypes at the D14MIT113 (LRS = 17.6; P = 3.6 x 10-4) and D14MIT203 (LRS = 15.7; P = 3.9 x 10-4) loci yielding respective LOD scores of 3.8 and 3.4 and recessive modes of inheritance (Fig. 3CGo).

To map BW modifier genes that could segregate with fertility, we analyzed BWs at various ages as a quantitative trait and found that the D5MIT271 locus is significantly associated with BW at 8 weeks of age (LRS = 22.9; P = 1.2 x 10-5) with a LOD score of 5.0 and a recessive mode of inheritance (Fig. 2DGo). However, this linkage decreases at later ages with respective LOD scores of 3.5, 2.5, 1.7, and 1.7 at 10, 12, 16, and 23 weeks of age, respectively, suggesting that this association gradually decreases with the development of morbid obesity. Previous linkage studies aimed at localizing obesity modifier loci in mouse crosses involved lean mice from different strains (21, 22, 23, 24); however, this study is the first to report BW modifiers in an obese state. Presumably, the effects of modifier genes on adiposity are more likely to be encountered in a cross involving morbid obesity such as the ob/ob phenotype due to the relative ease of detection of BW fluctuations and their relative stability over time. In summary, four loci on chromosomes 1, 3, 5, and 14 were identified and appear to affect the onset and extent of fertility in ob/ob mice on the mixed C57BL/6J-BALB/cJ genetic background. Thus, the fertility phenotype in F2 obese mice would be conferred by a combination of these loci and possibly by other loci yet to be uncovered.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous studies have shown that the severity of the diabetic-associated state of ob/ob and db/db mice is altered by the genetic background on which the mutation is maintained (25, 26). Thus, ob/ob and db/db mice bred on the C57BL/6J background had milder diabetes than when maintained on the C57BL/Ks background, pointing to the effects of background-specific modifier genes. Although the obese state directly influences diabetes, which tends to resolve after leptin treatment in ob/ob mice (27, 28, 29), our present findings demonstrate that the sterility of obese males is corrected in the absence of leptin via the action of BALB/cJ-derived modifier genes despite morbid obesity and hyperglycemia, which remained severe on this mixed genetic background at least until 23 weeks of age. Hence, transfer of the ob mutation onto the BALB/cJ background results in a profound change of an obesity-associated phenotype, in this case reproduction. Similarly, we transferred the ob mutation to the DBA/2J genetic background (data not shown) and observed that F2 ob/ob C57BL/6J-DBA/2J females remained sterile but that 7 of 16 F2 C57BL-DBA/2J obese males were fertile. The physiological basis for the onset of fertility in F2 obese mice could be at different levels, either peripheral, central, or both but must certainly result in maturation of the hypothalamic-pituitary- gonadal axis despite the diabetic and obese states imposed by the ob mutation. Examination of F2 C57BL-BALB ob/ob testes histology did not reveal any striking difference between fertile and sterile groups. However, there was a dramatic improvement in testes histology between F2 ob/ob males on the mixed background and ob/ob males on the C57BL/6J homogeneous background (data not shown). Oversecretion of testosterone in fertile obese males indicates that their fertility is mediated via restoration of a functioning feedback loop at the hypothalamic-pituitary-testicular axis. In contrast, this axis remains immature in obese sterile mice despite normal Leydig cells morphology, thus alluding to a reduced secretion of testosterone. The higher ratio of TW/BW in fertile mice vs. sterile mice suggests that TWs combined with the degree of adiposity influence the ability of obese mice to reproduce. On the other hand, sharing of the same haplotype at the D1MIT459 and D3MIT316 loci among fertile and sterile mice demonstrates that these two loci do not solely account for the fertility phenotype but that additional modifier loci are involved and remain to be identified.

Furthermore, while glucose levels were not significantly different between the two groups, they demonstrate that the transient hyperglycemia that is characteristic of young C57BL ob/ob mice and that recedes to normoglycemia and elevated insulin levels in older ob/ob mice (25) is similar in both fertile and sterile groups. Therefore, the diabetic state does not appear to affect the fertility of F2 obese males. The interesting correlation of triglyceride levels with glucose in fertile F2 obese mice suggests that perhaps the conversion of glucose to acetyl coenzyme A and its subsequent entry into the fatty acid synthesis pathway may be more efficient in fertile than sterile obese mice. Whether this is a contributing factor to fertility or a secondary effect remains to be determined.

Interestingly, the leptin-independent genetic rescue of sterility in F2 ob/ob mice in this cross was applicable only to obese males but not to obese females. The lack of fertility among females further reinforces the notion that leptin is essential for the initiation of reproduction in females and cannot be substituted, as in males, by the effects of modifier genes. This hypothesis is consistent with previous findings that show that leptin is a contributing factor to the initiation of female reproduction in normal mice (11, 12) and rats (13). Alternatively, it is possible that the sterility rescue of ob/ob females by this genetic approach necessitates the combination of additional modifier genes, thus decreasing the frequency of such an occurrence in a single animal as in the present F2 intercross. Instead, transfer of the ob mutation on a pure BALB/cJ background by 10 successive backcrosses followed by an F2 intercross will result in a congenic strain consisting of ob/ob mice homozygous for almost all BALB/cJ alleles. Assay of the resulting obese females for fertility will test the hypothesis whether additional BALB/cJ genes are needed for induction of fertility in obese females.

Finally, the uncovering of chromosomal regions spanning modifier genes that altogether rescue the sterility of morbidly obese mice provide an entrypoint to narrow down the regions of interest and subsequent characterization of candidate genes within such regions. Ultimate proof will emanate from an alteration in expression or DNA sequence of candidate genes between the C57BL/6J and BALB/cJ strains at the proposed locus. Alternatively, consomic strains segregating these particular loci will uncover the contribution of their effect on the observed phenotype. Eventually, the elucidation of these complex pathways will lead to a better understanding of obesity-associated reproductive disorders.

Received July 29, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Edman, CD, MacDonald PC 1978 Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 130:456–61[Medline]
  2. Plymate SR, Fariss BL, Bassett ML, Matej L 1981 Obesity and its role in polycystic ovary syndrome. J Clin Endocrinol Metab 52:1246–1248[Abstract/Free Full Text]
  3. Goldzieher JW, Green JA 1962 The polycystic ovary I Clinical and histological features. J Clin Endocrinol Metab 22:325-
  4. Vermeulen A, Kaufman JM, Giagulli VA 1966 Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81:1821–1826[Abstract]
  5. Tchernof A, Despres JP, Belanger A, Dupont A, Prud’homme D, Moorjani S, Lupien PJ, Labrie F 1995 Reduced testosterone and adrenal C19 steroid levels in obese men. Metab Clin Exp 44:513–519
  6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432[CrossRef][Medline]
  7. Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J, Hanitsch S, Attanasio A, Blum WF 1997 Levels of leptin in maternal serum amniotic fluid and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 82:480–483
  8. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K 1997 Non adipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 3:1029–1033[CrossRef][Medline]
  9. Chehab FF, Lim ME, Lu R 1996 Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12:318–320[CrossRef][Medline]
  10. Mounzih K, Lu R, Chehab FF 1997 Leptin treatment rescues the sterility of genetically obese ob/ob male. Endocrinology 138:1190–1193[Abstract/Free Full Text]
  11. Chehab FF, Mounzih K, Lu R, Lim ME 1997 Early onset of reproductive function in normal female mice treated with leptin. Science 275:88–90[Abstract/Free Full Text]
  12. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS 1997 Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 99:391–395[Medline]
  13. Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK, Steiner RA 1997 Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 138:855–858[Abstract/Free Full Text]
  14. Haley CS, Knott SA 1992 A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 69:315–324[Medline]
  15. Lander E, Kruglyack L 1995 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241–247[CrossRef][Medline]
  16. Doerge RW, Churchill GA 1996 Permutation tests for multiple loci affecting a quantitative character. Genetics 142:285–294[Abstract]
  17. Hellman B 1965 Studies in obese-hyperglycemic mice. Ann NY Acad Sci 121:541–559
  18. Swerdloff RS, Batt RA, Bray GA 1976 Reproductive hormonal function in the genetically (ob/ob) mouse. Endocrinology 98:1359–1364[Abstract/Free Full Text]
  19. Kuhn-Velten N, Codjambopoulo P, Haider SG, Passia D, Kley HK, Herberg L, Staib W, Goslar HG 1986 Biochemical and histochemical studies on the pituitary-testicular axis in obese (C57Bl/6J-ob/ob) mice. Int J Androl 9:123–131[Medline]
  20. Chubb C 1989 Genetically defined mouse models of male infertility. J Androl 10:77–88[Abstract/Free Full Text]
  21. Taylor BA, Philips SJ 1997 Obesity QTLs on mouse chromosomes 2 and 17. Genomics 43:249–257[CrossRef][Medline]
  22. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau J, Lusis AJ, Bouchard C 1997 Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240–1247[Medline]
  23. Cheverud JM, Routman EJ, Duarte FA, van Swinderen B, Cothran K, Perel C 1996 Quantitative trait loci for murine growth. Genetics 142:1305–1319[Abstract]
  24. Keightley PD, Hardge T, May L, Bulfield G 1996 A genetic map of quantitative trait loci for body weight in the mouse. Genetics 142:227–235[Abstract]
  25. Coleman DL, Hummel KP 1973 The influence of genetic background on the expression of the obese (ob) gene in the mouse. Diabetologia 9:287–293[CrossRef][Medline]
  26. Hummel KP, Coleman DL, Lane P 1972 The influence of genetic background on expression of mutations at the diabetes locus in the mouse I C57BL/KsJ and C57BL/6J strains. Biochem Genet 7:1–13[CrossRef][Medline]
  27. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540–543[Abstract/Free Full Text]
  28. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543–546[Abstract/Free Full Text]
  29. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL 1995 Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96:2065–2070



This article has been cited by other articles:


Home page
GeneticsHome page
H. Chun and S. Keles
Expression Quantitative Trait Loci Mapping With Multivariate Sparse Partial Least Squares Regression
Genetics, May 1, 2009; 182(1): 79 - 90.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. L. Piper, E. K. Unger, M. G. Myers Jr., and A. W. Xu
Specific Physiological Roles for Signal Transducer and Activator of Transcription 3 in Leptin Receptor-Expressing Neurons
Mol. Endocrinol., March 1, 2008; 22(3): 751 - 759.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
G. G. Gosman, H. I. Katcher, and R. S. Legro
Obesity and the role of gut and adipose hormones in female reproduction
Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, W.-g. Ma, L. Tejada, H. Zhang, J. D. Morrow, S. K. Das, and S. K. Dey
Rescue of Female Infertility from the Loss of Cyclooxygenase-2 by Compensatory Up-regulation of Cyclooxygenase-1 Is a Function of Genetic Makeup
J. Biol. Chem., March 12, 2004; 279(11): 10649 - 10658.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Matsunuma, T. Kawane, T. Maeda, S. Hamada, and N. Horiuchi
Leptin Corrects Increased Gene Expression of Renal 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase and -24-Hydroxylase in Leptin-Deficient, ob/ob Mice
Endocrinology, March 1, 2004; 145(3): 1367 - 1375.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. V. Tortoriello, J. McMinn, and S. C. Chua
Dietary-Induced Obesity and Hypothalamic Infertility in Female DBA/2J Mice
Endocrinology, March 1, 2004; 145(3): 1238 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
F. F. Chehab, J. Qiu, and S. Ogus
The Use of Animal Models to Dissect the Biology of Leptin
Recent Prog. Horm. Res., January 1, 2004; 59(1): 245 - 266.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Legro, R. Bentley-Lewis, D. Driscoll, S. C. Wang, and A. Dunaif
Insulin Resistance in the Sisters of Women with Polycystic Ovary Syndrome: Association with Hyperandrogenemia Rather Than Menstrual Irregularity
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2128 - 2133.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Sainsbury, C. Schwarzer, M. Couzens, A. Jenkins, S. R. Oakes, C. J. Ormandy, and H. Herzog
Y4 receptor knockout rescues fertility in ob/ob mice
Genes & Dev., May 1, 2002; 16(9): 1077 - 1088.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. M. Malik, N. D. Carter, J. F. Murray, R. J. Scaramuzzi, C. A. Wilson, and M. J. Stock
Leptin Requirement for Conception, Implantation, and Gestation in the Mouse
Endocrinology, December 1, 2001; 142(12): 5198 - 5202.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. FRUHBECK and J. GOMEZ-AMBROSI
Rationale for the existence of additional adipostatic hormones
FASEB J, September 1, 2001; 15(11): 1996 - 2006.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Qiu, S. Ogus, K. Mounzih, A. Ewart-Toland, and F. F. Chehab
Leptin-Deficient Mice Backcrossed to the BALB/cJ Genetic Background Have Reduced Adiposity, Enhanced Fertility, Normal Body Temperature, and Severe Diabetes
Endocrinology, August 1, 2001; 142(8): 3421 - 3425.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. Resto, D. O'Connor, K. Leef, V. Funanage, M. Spear, and R. Locke
Leptin Levels in Preterm Human Breast Milk and Infant Formula
Pediatrics, July 1, 2001; 108(1): e15 - 15.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. E. Jones and L. S. Lubbers
Suppression and recovery of estrous behavior in Syrian hamsters after changes in metabolic fuel availability
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1393 - R1398.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ewart-Toland, A.
Right arrow Articles by Chehab, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ewart-Toland, A.
Right arrow Articles by Chehab, F. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals